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Abstract: Induced pluripotent stem cells formed by the introduction of only three factors, 
Oct4/Sox2/Klf4 (3-gene iPSCs), may provide a safer option for stem cell-based therapy 
than  iPSCs  conventionally  introduced  with  four-gene  iPSCs.  Peroxisome  
proliferator-activated  receptor  gamma  coactivator-1α  (PGC-1α)  plays  an  important  role 
during  brown  fat  development.  However,  the  potential  roles  of  PGC-1α  in  regulating 
mitochondrial  biogenesis  and  the  differentiation  of  iPSCs  are  still  unclear.  Here,  we 
investigated the effects of adenovirus-mediated PGC-1α overexpression in 3-gene iPSCs. 
PGC-1α overexpression resulted in increased mitochondrial mass, reactive oxygen species 
production,  and  oxygen  consumption.  Microarray-based  bioinformatics  showed  that  the 
gene expression pattern of PGC-1α-overexpressing 3-gene iPSCs resembled the expression 
pattern observed in adipocytes. Furthermore, PGC-1α overexpression enhanced adipogenic 
differentiation  and  the  expression  of  several  brown  fat  markers,  including  uncoupling 
protein-1, cytochrome C, and nuclear respiratory factor-1, whereas it inhibited the expression 
of  the  white  fat  marker  uncoupling  protein-2.  Furthermore,  PGC-1α  overexpression 
significantly suppressed osteogenic differentiation. These data demonstrate that PGC-1α 
directs the differentiation of 3-gene iPSCs into adipocyte-like cells with features of brown 
fat  cells.  This  may  provide  a  therapeutic  strategy  for  the  treatment  of  mitochondrial 
disorders and obesity. 
Keywords:  induced  pluripotent  stem  cell;  c-Myc;  peroxisome  proliferator-activated 
receptor gamma coactivator-1α; brown adipocyte 
 
1. Introduction 
Stem cells have the potential for self-renewal and the ability to differentiate into many types of  
cells [1–3]. Recent techniques have demonstrated that induced pluripotent stem cells (iPSCs) can be 
generated  from  mouse  embryonic  fibroblasts  (MEFs)  and  human  fibroblasts  via  the  retroviral 
transduction  of  four  transcription  factors:  Oct-4,  Sox2,  Klf4  and  c-Myc  [4,5].  These  cells  are 
considered a promising resource for restorative cell therapy with a wide range of clinical applications 
for the treatment of different diseases. We recently demonstrated that iPSCs expressing only three 
factors, Oct4/Sox2/Klf4 (3-gene iPSCs), were capable of differentiating into hepatocyte-like cells, and Int. J. Mol. Sci. 2011, 12  7556 
 
 
the exclusion of the oncogene c-Myc resulted in decreased tumorigenicity [6]. These findings indicate 
that 3-gene iPSCs may be a safer alternative for stem cell-based therapy. 
PGC-1α (peroxisome proliferator-activated  receptor gamma  coactivator-1α) was isolated from a 
brown fat library used to identify peroxisome proliferator-activated receptors γ (PPARγ)-interacting 
proteins.  It  regulates the expression of the uncoupling protein-1 (UCP-1)  gene and several brown  
fat-selective genes during brown fat development [7]. This energy induced transcription coactivator is 
highly responsive to a variety of environmental cues, including temperature changes, nutritional status, 
and physical activity [8]. Multiple diseases caused by dysregulation of metabolism are known to be 
caused  by  aberrant  PGC-1α  expression  [9].  However,  the  potential  role  of  PGC-1α  in  regulating 
mitochondrial biogenesis and the differentiation of iPSCs is still unclear. 
Because PGC-1α serves an important role in brown fat development, we aimed to determine if 
PGC-1α can mediate the differentiation of 3-gene iPSCs into adipose-specific lineages. In this study, 
we show that adenovirus-mediated PGC-1α overexpression led to increased mitochondrial mass and  
an  increase  in  reactive  oxygen  species  (ROS)  production  and  O2  consumption.  Microarray-based 
bioinformatics demonstrated that the gene expression pattern of PGC-1α-overexpressing 3-gene iPSCs 
resembled  the  expression  pattern  of  adipocytes.  Furthermore,  PGC-1α  overexpression  enhanced 
adipogenic differentiation and the expression of several brown fat markers but suppressed osteogenic 
differentiation. These findings demonstrate an important role for PGC-1α in promoting the differentiation 
of 3-gene iPSCs into brown fat cells.  
2. Results and Discussion 
2.1. Characterization of 3-Gene iPSCs 
We used retroviruses to express the three reprogramming factors (Oct4/Sox2/Klf4) in MEFs, as 
previously  described  [6].  A  resulting  clone  was  positive  for  alkaline  phosphatase  expression  
(Figure 1A, upper) and the embryonic stem (ES) cell markers Oct-4 and Nanog (Figure 1B). After 
being treated with differentiation protocols specific for three separate dermal lineages, these 3-gene 
iPSCs could be differentiated into neuron-like cells (ectoderm), adipocyte-like cells (mesoderm) and 
hepatocyte-like  cells  (endoderm)  (Figure  1A,  lower).  PGC-1α  is  considered  a  key  molecule  in 
regulating mitochondrial biogenesis and stem cell differentiation [7]. To investigate whether PGC-1α 
affects differentiation, we overexpressed PGC-1α in 3-gene iPSCs using an adenoviral system. iPSCs 
were efficiently infected with an adenovirus expressing GFP, and infection rates greater than 90% 
were routinely observed (Figure 1C and 1D). The expression of PGC-1α mRNA was consistently 
upregulated in ES cells 5 and 10 days after adenoviral transduction (Figure 1E).  Int. J. Mol. Sci. 2011, 12  7557 
 
 
Figure 1. Characterization of 3-gene iPSCs overexpressing PGC-1α. (A) Upper: colonies 
of 3-gene iPSCs positive for alkaline phosphatase. Lower: differentiation of 3-gene iPSCs 
into ecto- (left), meso- (middle), and endo- (right) dermal lineages; (B) The iPSC colonies 
were positive for Oct-4 and Nanog; (C) Three-genes iPSCs were visualized using phase 
contrast microscopy; and (D) fluorescence microscopy 5 days after adenoviral infection; (E) 
RT-PCR  analysis  of  PGC-1α  expression  in  3-gene  iPSCs  infected  with  the  adenovirus 
expressing PGC-1α at 5 and 10 days post-transduction; (F) Relative changes in mitochondrial 
mass; (G) Relative changes in ROS production; (H) Relative oxygen consumption. 
 
 
2.2. Increased Mitochondrial Mass and Activity in PGC-1α-Overexpressing 3-Gene iPSCs 
Previous data have shown that PGC-1α stimulates mitochondrial biogenesis, resulting in increased 
mitochondrial mass and respiration [10]. Therefore, we first investigated the changes in mitochondrial 
mass  in  3-gene  iPSCs  overexpressing  PGC-1α.  The  mitochondrial  mass  increased  over  time  in  Int. J. Mol. Sci. 2011, 12  7558 
 
 
PGC-1α-overexpressing cells compared to the controls (Figure 1F). Increased oxygen consumption is 
critical for PGC-1α-mediated mitochondrial activity during adipogenic differentiation. Therefore, we 
investigated the oxygen consumption of these cells using an oxygen-sensing electrode and measured 
the expression of reactive oxygen species (ROS) produced during mitochondrial biogenesis. PGC-1α 
significantly increased oxygen consumption 5 and 10 days post-transduction (Figure 1H). We also 
found a significant increase in ROS levels post-transduction (Figure 1G). These data indicate enhanced 
mitochondrial respiration in PGC-1α-overexpressing 3-gene iPSCs. 
2.3. Genetic Profiling of 3-Gene iPSC Overexpressing PGC-1α 
We  next  analyzed  the  gene  expression  profile  of  PGC-1α-overexpressing  3-gene  iPSCs  using 
microarray analysis. The expression profiles were performed by Affymetrix Mouse Genome 430 2.0 
Array, which contain 45101 probe sets selected from GenBank, dbEST, and RefSeq. Each gene may 
be detected by more than one probe. Using statistical methods to select 1000 probe IDs (p-value < 1E-10) 
which had the most significant expression difference, a total of 719 genes were differentially expressed 
in PGC-1α-overexpressing 3-gene iPSCs compared with GFP-expressing 3-gene iPSCs (Figure 2A). 
Furthermore,  the  average  linkage  distance  analysis  suggested  that  the  gene  expression  profile  of  
PGC-1α-overexpressing iPSCs was closer to the gene signature of adipose tissue than the expression 
profile of GFP-expressing 3-gene iPSCs (Figure 2C). Functional characterization of the significantly 
upregulated genes in PGC-1α-overexpressing 3-gene iPSCs during adipogenesis was performed using 
Gene Ontology. The processes associated with the upregulated genes and those that were represented 
significantly more than expected (p < 0.01), as identified by gene ontology, were primarily related to 
electron  transport,  cellular  respiration,  the  generation  of  precursor  metabolites  and  energy,  the 
tricarboxylic acid cycle, fatty acid beta-oxidation, and carboxylic acid metabolic processes (Figure 2B). 
All of these pathways are necessary for mitochondrial function during adipogenic differentiation. 
2.4. PGC-1α Enhances Adipogenesis and Inhibits Osteogenesis 
Recently,  an  inverse  relationship  between  adipogenesis  and  osteogenesis  was  shown  in 
mesenchymal stem cells [2]. We further investigated whether PGC-1α overexpression modulates the 
differentiation of 3-gene iPSCs into adipocyte-like cells or osteocyte-like cells. As detected using Oil 
Red O staining, PGC-1α enhanced the adipogenic differentiation of iPSCs compared to the differentiation 
of GFP-expressing 3-gene iPSCs under adipogenic conditions (Figure 3A and 3B). Notably, PGC-1α 
expression also prevented the osteogenic differentiation of 3-gene iPSCs under osteogenic conditions, 
as  detected  using  Alizarin  Red  staining  (Figure  3C  and  3D).  These  results  suggest  that  PGC-1α 
enhances adipogenesis but prevents osteogenesis. Int. J. Mol. Sci. 2011, 12  7559 
 
 
Figure 2. Gene expression profile of 3-gene iPSCs, PGC-1α-overexpressing 3-gene iPSCs 
and  adipose  tissue.  (A)  Gene  expression  microarray  analysis  showing  genes  that  were 
differentially  expressed  among  the  three  cell  types  using  a  hierarchy  heat  map; 
(B) Functional classification of the genes upregulated in PGC-1α-overexpressing 3-gene 
iPSCs compared to GFP-expressing 3-gene iPSCs, as determined by their Gene Ontology 
category;  (C)  Multidimensional  Scaling  further  showed  that  the  expression  profile  of  
PGC-1α -overexpressing 3-gene iPSCs was closer to the genetic signature of adipose tissue 
than the signature of 3-gene iPSCs. 
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Figure  3.  PGC-1α  inhibits  osteogenesis  but  enhances  adipogenesis  of  3-gene  iPSCs. 
(A) Uninfected 3-gene iPSCs (as a control) or 3-gene iPSCs infected with an adenovirus 
expressing GFP (m.o.i. = 500) or PGC-1α (m.o.i. = 100/500) were cultured in adipogenic 
conditions for 10 days. After differentiation, the cells were stained with Oil Red O; and 
(B) staining  was  quantified  using  a  spectrophotometer.  The  results  are  presented  as  the  
mean ± SE of three independent experiments; (C) Uninfected 3-gene iPSCs (as a control) 
or  3-gene  iPSCs  infected  with  an  adenovirus  expressing  GFP  (m.o.i.  =  500)  or  
PGC-1α  (m.o.i.  =  100/500)  were  cultured  in  osteogenic  conditions  for  10  days.  After 
differentiation, the cells were stained with Alizarin Red; and (D) staining was quantified using a 
spectrophotometer. The results are expressed as the mean ± SE of three independent experiments. 
 
2.5. Upregulation of Brown Fat Markers in PGC-1α-Expressing 3-Gene iPSCs during  
Adipogenic Differentiation 
Two functionally different types of fat are present in mammals: white adipose tissue, which is the 
primary  site  for  triglyceride  storage,  and  brown  adipose  tissue,  which  is  specialized  for  energy 
expenditure. To determine if PGC-1α-overexpressing 3-gene iPSCs preferentially differentiated into a 
specific  type  of  adipose  tissue,  qRT-PCR  was  used  to  analyze  the  expression  of  adipose-specific Int. J. Mol. Sci. 2011, 12  7561 
 
 
markers. Adenovirus-mediated PGC-1α overexpression resulted in the upregulation of UCP-1, a brown 
fat marker, at day 5 post-differentiation. The upregulation of UCP-1 expression was further enhanced 
in cells overexpressing PGC-1α at day 10 post-differentiation (Figure 4A). In addition, we observed 
that  PGC-1α  significantly  increased  the  expression  of  genes  involved  in  mitochondrial  function, 
including cytochrome C and nuclear respiratory factor-1 (NRF-1) (Figure 4B and 4D), in agreement 
with the mitochondria biogenesis data. In contrast, the expression of UCP-2, a white fat marker, was 
significantly  reduced  in  PGC-1α-overexpressing  3-gene  iPSCs  compared  to  GFP-expressing  cells 
(Figure 4C). Furthermore, the protein levels of these adipocyte-related markers were also assessed. 
Protein expression of PGC-1α and UCP-1 was significantly higher in PGC-1α-overexpressing 3-gene 
iPSCs than in control GFP-expressing 3-gene iPSCs at 5 and 10 days post-differentiation (Figure 4E). 
These findings reveal that PGC-1α directed the differentiation of 3-gene iPSCs into brown adipocytes, 
resulting in the upregulation of genes involved in brown fat differentiation and mitochondrial function. 
Figure 4. PGC-1α overexpression directs the differentiation of 3-gene iPSCs into brown 
adipocyte  tissue  during  adipogenic  induction.  The  mRNA  level  of  (A)  UCP-1; 
(B) cytochrome C; (C) UCP-2; and (D) NRF-1 was examined using qRT-PCR. The data 
are presented as the mean ± SD (n = 3); (E) The protein expression of PGC-1α, UCP-1 and 
UCP-2 was examined using western blotting. The data are presented as the mean ± SD  
(n = 3). 
 
2.6. Discussion 
In this study, our data demonstrate that PGC-1α can promote the differentiation of 3-gene iPSCs 
into  brown  adipocytes  with  an  accompanying  increase  in  mitochondrial  biogenesis  and  UCP-1 
expression. In contrast, the white fat marker UCP-2 was downregulated following PGC-1α expression. 
Moreover,  PGC-1α  inhibited  the  differentiation  of  3-gene  iPSCs  into  osteocyte-like  cells  when Int. J. Mol. Sci. 2011, 12  7562 
 
 
cultured in osteogenic conditions. These results suggest that PGC-1α not only mediates mitochondrial 
biogenesis and respiration but is also involved in the development of brown adipose tissue. 
Previous data have demonstrated that mice deficient in PGC-1α are cold sensitive and their brown 
fat  tissue  appears  morphologically  abnormal,  with  abundant  accumulation  of  large  lipid  droplets, 
reminiscent  of  white  adipose  tissue  [11].  The  PGC-1α  null  mice  also  presented  with  a  complex 
neurological disorder and neurodegeneration-associated hyperactivity [11,12]. These results suggest 
that genetic knockout of PGC-1α causes profound disturbances in energy homeostasis in addition to 
functional abnormalities in several tissues, including the liver, brown fat, brain, and heart [11]. Recent 
data using brown fat cells lacking PGC-1α demonstrated that there are significant defects in the ability 
of these cells to activate the program of gene expression linked to thermogenesis [13]. Uldry et al. also 
investigated whether the absence of PGC-1α can be compensated for by the presence of PGC-1β. Their 
data  showed  that  a  deficiency  in  either  PGC-1α  or  β  causes  a  small  but  significant  decrease  in 
mitochondrial gene expression. However, a deficiency in both PGC-1α and β causes a total loss of 
mitochondrial biogenesis and respiration [13]. This indicates that there is a strong requirement for 
either PGC-1α or β to maintain mitochondrial gene expression, density, and respiration. In the present 
study, our findings demonstrate that increased PGC-1α expression can increase mitochondrial mass, 
respiration and mitochondrial gene expression, including the expression of cytochrome C and NRF-1, 
and are consistent with previous findings. 
iPSCs have been reported to differentiate into various lineages, including osteoblasts, chondrocytes, 
cardiomyocytes and adipocytes [6,14–16]. However, whether iPSC-derived adipocytes possess features 
of brown adipose tissue has not been examined. In addition, mitochondria play an important role the 
generation of heat by brown fat, and PGC-1 coactivators regulate several aspects of mitochondrial 
biogenesis  and  activity.  The  results  of  the  Oil  Red  O  staining  indicate  that  PGC-1α  enhanced 
adipogenesis under adipogenic conditions. In addition, we observed a significant increase in UCP-1 
expression  and  a  decrease  in  UCP-2  expression  in  PGC-1α-overexpressing  3-gene  iPSCs-derived 
adipocytes (Figure 4A, 4C, and 4E). Other mitochondrial genes, such as cytochrome C and NRF-1, 
were  upregulated  in  PGC-1α-overexpressing  3-gene  iPSCs  during  adipogenic  differentiation  
(Figure 4B and 4D). Moreover, microarray analysis indicated that the upregulated genes in PGC-1α-
overexpressing 3-gene iPSCs are predominantly associated with the carboxylic acid metabolism, the 
generation of precursor metabolites and energy, electron transport, and fatty acid oxidation. These 
results  suggest  that  PGC-1α  is  involved  not  only  in  thermogenesis  but  also  in  promoting  the 
differentiation  of  3-gene  iPSCs  into  brown  fat.  However,  a  recent  report  has  claimed  that  while  
PGC-1α  is  not  required  for  brown  fat  differentiation,  it  does  participate  in  differentiation-induced 
mitochondrial  biogenesis  [13].  This  discrepancy  could  be  due  to  the  fact  that  Uldry  et  al.  used 
immortalized  preadipocytes  for  their  experiments  and  that  these  cells  have  limited  differentiation 
potential. To confirm whether PGC-1α is essential for adipose differentiation, it will be necessary to 
knockout  PGC-1α  to  examine  the  effect  of  its  loss  on  brown  adipogenic  differentiation.  The 
predisposition toward brown fat adipogenesis in PGC-1α-overexpressing 3-gene iPSCs suggests that 
PGC-1α may determine the direction of differentiation for iPSCs during adipose development. It will 
be  interesting  to  explore  the  upstream  factors  regulating  the  activity  of  PGC-1  activators  and  the 
downstream targets mediated by PGC-1α during brown fat differentiation. Future investigations are 
necessary to elucidate the relationship between PGC-1α and adipogenesis.  Int. J. Mol. Sci. 2011, 12  7563 
 
 
The incidence of in vivo teratoma formation has been a major unresolved problem for iPSC-based 
transplantation [14]. The c-Myc oncogene can contribute to tumorigenesis by over-stimulating cell 
growth  and  metabolism  and/or  by  causing  genomic  instability.  Deregulated  expression  of  c-Myc 
occurs in a wide range of human cancers and is often associated with a poor prognosis, indicating a 
key  role  for  this  oncogene  in  tumor  progression  [17].  To  eliminate  teratoma  formation,  some 
alternative experimental approaches have been used in several studies. One recent study demonstrated 
that replacing c-Myc with L-Myc in combination with Oct4/Sox2/Klf4 promoted iPSC generation but 
not tumor formation [18]. Tsuji et al. demonstrated that transplantation of neurospheres derived from 
safe iPSC clones into injured spinal cords promoted functional recovery without teratoma formation [19]. 
Our recent study demonstrated that iPSCs expressing only three factors (Oct4/Sox2/Klf4) can provide 
a safer resource for stem cell-based therapy. The findings in the present study also suggest that 3-gene 
iPSCs may be an ideal platform for in vitro studies or drug screening. 
3. Materials and Methods 
3.1. iPSC Culture and Microarray Analysis 
The  iPSCs  were  reprogrammed  via  retroviral  vectors  expressing  three  transcription  factors  
(Oct-4/Sox2/Klf4). iPSC culture, maintenance, and microarray analysis were conducted as described 
previously [6]. Briefly, total RNA was extracted from cells using Trizol (Life Technologies, Bethesda, 
MD, USA) and the Qiagen RNeasy (Qiagen, Valencia, CA, USA) column for purification. cRNA 
probe preparation, array hybridization and data analysis were performed according to Affymetrix
TM 
recommendations. Affymetrix
TM Mouse Genome 430 2.0 whole genome chips were used. RMA log 
expression units were calculated from Affymetrix GeneChip array data using the Bioconductor [20] 
software suite for the R statistical programming language [21]. The default RMA settings were used to 
background correct, normalize and summarize all expression values. Significant differences between 
sample groups were identified using the ‘limma’ package of Bioconductor. Briefly, a t-statistic was 
calculated as normal for each gene, and then a p-value was calculated using a modified permutation 
test. To control for multiple testing errors, a false discovery rate (FDR) algorithm was applied to these 
p-values  to  calculate  a  set  of  q-values,  which  are  thresholds  of  the  expected  proportion  of  false 
positives,  or  false  rejections,  of  the  null  hypothesis.  A  heat  map  was  created  using  the  dChip  
software [22]. Gene annotation and gene ontology were performed using the DAVID Bioinformatics 
Resources 6.7 interface[23]. 
3.2. Adenoviral Expression System 
The adenovirus used in this study contains, in tandem, the green fluorescent protein (GFP) gene  
and  the  human  PGC-1α  cDNA  downstream  of  separate  cytomegalovirus  promoters.  Adenoviruses 
containing only GFP (Ad-GFP) or the antisense sequence of PGC-1α (Ad-AS-PGC-1α) were used as 
controls. Prior to adipocyte differentiation, 3-gene iPSCs were infected with Ad-GFP, Ad-AS-PGC-1α, 
or Ad-PGC-1α at a multiplicity of infection (m.o.i.) of 100 or 500 overnight. The medium was then 
changed to differentiation medium as described above. After the infected cells were cultured for 3 or 7 Int. J. Mol. Sci. 2011, 12  7564 
 
 
days, total RNA or total cell lysates were collected for the subsequent analysis of gene or protein 
expression, respectively. 
3.3. Reverse Transcription Polymerase Chain Reaction (RT-PCR) and Quantitative RT-PCR 
RT-PCR  and  qRT-PCR  were  used  to  determine  the  expression  of  PGC-1α.  The  RT-PCR  and  
qRT-PCR were conducted as described previously [6]. The primer sequences used for RT-PCR are 
shown in Table 1. 
Table 1. The sequences for the primers of RT-PCR. 
Gene  Primer sequence 
GAPDH  Forward:5'-CCC CAC ACA CAT GCA CTT ACC-3' 
Reverse:5'-CCT ACT CCC AGG GCT TTG ATT-3' 
PGC-1α  Forward:5-ATGCACTGACAGATGGAGACGTGAC-3' 
Reverse:5-GTTCCTATACCATAGTCATGCATTG-3' 
UCP-1  Forward:5'-TGGAATAGCGGCGTGCTTG-3' 
Reverse:5'-CTCATCAGATTGGGAGTAG-3' 
UCP-2  Forward:5'-TCTACAATGGGCTGGTTGC-3'  
Reverse:5'-TGTATCTCGTCTTGACCAC-3' 
NRF-1  Forward:5′-ACTGGAATTCCGTCGATGGTGAGA-3′ 
Reverse:5′-ACCTGACACAACACGGACAGAACT-3′ 
Cytochrome C  Forward:5'-ACGTGTCGACCTAATATGGGTGATGTTGAAAAAGG-3′ 
Reverse:5'-ACAGATCTTTCTCATTAGTAGCCTTTTTAAG-3′ 
3.4. Detection of Reactive Oxygen Species (ROS) 
Production of ROS from 3-gene iPSCs was measured using hydroethidine (HE; Molecular Probes). 
Cells were incubated with 10 µM HE in culture medium for 60 min at 37 °C, washed, resuspended in 
0.5 mL PBS and analyzed using flow cytometry.  
3.5. Detection of Mitochondrial Mass 
The mitochondrial mass was measured using the probe MitoTracker Red 580 (Invitrogen). Cells 
were incubated with 200 nM MitoTracker Red 580 in PBS for 15 min at 37 °C and then analyzed 
using flow cytometry. 
3.6. Oxygen Consumption 
The  respiration  of  adipocytes  was  measured  using  an  oxygen  electrode  (MT200/MT200A 
Respirometer Cell, Strathkelvin Instruments, North Lanarkshire, Scotland). PGC-1α- or GFP-expressing 
3-gene  iPSCs  were  trypsinized  and  rinsed  with  PBS.  The  cells  were  resuspended  in  DMEM-LG 
without supplements. Each sample (10
6 cells) was analyzed during incubation in a magnetically stirred 
chamber over a period of 5 min at constant temperature (37 °C). The signals were detected and analyzed 
using software from Strathkelvin Instruments. The rate of oxygen consumption was normalized to the Int. J. Mol. Sci. 2011, 12  7565 
 
 
number of living cells, which was determined using Trypan Blue staining and counting cells using  
a hemocytometer. 
3.7. Adipogenic Differentiation 
Adipogenic induction was conducted as previously described [15]. iPSCs (1 × 10
5) were cultured in 
adipogenic  medium  for  3  weeks.  The  adipogenic  medium  consisted  of  DMEM-LG  supplemented  
with 10% FBS, 50 µg/mL ascorbate-2 phosphate, 100 nM dexamethasone, and 50 µM indomethacin 
(Sigma). For the evaluation of adipocytes, the cells were fixed with 4% formaldehyde and stained with 
Oil Red O (Sigma). Neurogenesis was assessed using the expression of nestin and other neural markers 
on days 7 and 14. 
3.8. Osteogenic Differentiation 
For osteogenic induction, iPSCs were cultured in DMEM-LG (Invitrogen) supplemented with 15% 
FBS, 50 µg/mL ascorbate-2-phosphate, 10 nmol/L dexamethasone, and 10 mmol/L β-glycerophosphate 
(Sigma, St. Louis, MO, USA) for 2 weeks. At the end of osteogenic induction, the cells were washed 
twice with PBS, fixed for 10 min at room temperature in 3.7% paraformaldehyde, and stained with von 
Kossa stain and Alizarin Red to assess osteogenic differentiation [1,2]. 
3.9. Statistical Analysis 
All data are expressed as the mean ± standard deviation (SD). A one- or two-way ANOVA was 
used  to  determine  the  statistical  significance  of  the  differences.  A  p  value  less  than  0.05  was 
considered significant. The statistics software used in this study was Sigma Stat 3.0.1 (SPSS, Chicago, 
IL, USA). 
4. Conclusions 
Mitochondrial  dysfunction  in  adipocytes  has  been  associated  with  obesity  [24]  and  type  2  
diabetes  [25].  The  major  advantage  of  iPSCs  over  ES  cells  is  that  iPSCs  can  be  derived  from  a 
patient’s own somatic cells, thereby avoiding immune rejection after transplantation and the ethical 
concerns raised by ES cells [4,5,26–28]. Factors that increase the PGC-1α level can be expected to 
drive iPSCs toward brown fat cells and mitochondrial biogenesis and respiration. BMP7 is a potential 
candidate  that  promotes  brown  adipose  differentiation  and  thermogenesis  via  the  upregulation  of  
PGC-1α and other factors [29]. For iPSC-based treatment of obesity or mitochondrial disorders, it is 
plausible  to  contemplate  the  generation  of  patient-specific  3-gene  iPSCs  with  high  expression  of  
PGC-1α.  Transplantation  of  these  iPSCs  may  provide  a  novel  strategy  for  the  treatment  of  these 
diseases. Future studies are required to verify the therapeutic potential of these strategies. 
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